All FDA drug approvals

FDA data · free, no account

FDA drug approvals in 1962

FDA approved the original submission of 29 new drug and biologics license applications in 1962, from 22 sponsors. FDA marks 26 of them discontinued, every product under the application. From the Drugs@FDA export of 2026-09-03.

ApprovedBrandIngredientSponsorApplication
ALDOMETmethyldopaMERCKNDA013400
ALDOMETmethyldopate hydrochlorideMERCKNDA013401
ALDORIL 15hydrochlorothiazide, methyldopaMERCKNDA013402
VALPIN 50anisotropine methylbromideENDO PHARMSNDA013428
DECA-DURABOLINnandrolone decanoateWOODWARD SPECLNDA013132
DEXACORTdexamethasone sodium phosphateUCB INCNDA013413
URACIL MUSTARDuracil mustardSHIRENDA012892
GRISACTINgriseofulvin, microcrystallineWYETH AYERSTNDA050051
CONRAY 43iothalamate meglumineLIEBEL-FLARSHEIMNDA013295
SKELAXINmetaxaloneKING PHARMSNDA013217
DECADRON W/ XYLOCAINEdexamethasone sodium phosphate, lidocaine hydrochlorideMERCKNDA013334
ORAGRAFIN SODIUMipodate sodiumBRACCONDA012967
MAXIDEXdexamethasoneHARROW EYENDA013422
ORTHO-NOVUM 1/50 21mestranol, norethindroneORTHO MCNEIL PHARMNDA012728
COLY-MYCIN Scolistin sulfate, hydrocortisone acetate, neomycin sulfate, thonzonium bromidePH HEALTHNDA050356
TARACTANchlorprothixeneROCHENDA012486
PENTHRANEmethoxyfluraneABBOTTNDA013056
FLUOROURACILfluorouracilSPECTRUM PHARMSNDA012209
HEXADROLdexamethasoneASPEN GLOBAL INCNDA012675
ARTANEtrihexyphenidyl hydrochlorideLEDERLENDA012947
PERIACTINcyproheptadine hydrochlorideMERCKNDA013220
TARACTANchlorprothixeneROCHENDA012487
NOVRADlevopropoxyphene napsylate anhydrousLILLYNDA012928
MELLARILthioridazine hydrochlorideNOVARTISNDA011808
ORAGRAFIN CALCIUMipodate calciumBRACCONDA012968
QUINIDEXquinidine sulfateWYETH PHARMS INCNDA012796
SANSERTmethysergide maleateNOVARTISNDA012516
DIAMOXacetazolamideTEVA BRANDED PHARMNDA012945
WINSTROLstanozololLUNDBECK INCNDA012885